Researcher in the lab, preparing the vaccine for use in the nebulizer. Photographer: Georgia Kirkos

Researchers to begin human trials for promising new inhaled COVID-19 vaccines designed to combat variants of concern

Posted on

Human trials are set to begin for two next-generation COVID-19 vaccines developed by a team of scientists at McMaster University.

Both are designed to combat variants of concern and will be delivered by inhaled aerosol, not by injection, and will target the lungs and upper airways, where respiratory infections begin.

These are two of the very few COVID-19 vaccines being developed in Canada. Phase 1 of the clinical trials was recently approved by Health Canada….

https://brighterworld.mcmaster.ca/articles/researchers-to-begin-human-trials-for-promising-new-inhaled-covid-19-vaccines-designed-to-combat-variants-of-concern/

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]